Roche announced on the 15th that it will acquire GenMark Diagnostics, a US molecular pathology laboratory manufacturer, for US$1.8 billion.

Reported by CCTV news on Oct. 16th, variety of countries need to enlarge the test method to speed up the diagnosis on COVID-19. Some of the countries used the faster and cheaper test methods to overcome the bottleneck of inadequate capabilit

Recently, Gofar issued a report (draft) on the acquisition of KOALSON, proposing to purchase the 99.9779% of KOALSON's shares held by eight people with the transaction price of about 356 million yuan by issuing shares and paying cash.

COVID-19 screening can soon be conducted directly at various testing stations, and patients can get their test results in about an hour from the time they get a nasal swab.

Siemens Healthineers is adding more firepower in the fight to make more novel coronavirus (SARS-CoV-2) diagnostics available. The company said its Fast Track Diagnostics (FTD) SARS-COV-2 Assay is already being shipped in Europe for research

The Austin TX-based company was granted Emergency Use Authorization for the Aries SARS-CoV-2 Assay and the NxTAG CoV Extended Panel to help in the detection of the novel coronavirus.

RocheGets Ventana in the End Roche went through a lot (and we do mean a lot) to acquire Ventana Medical Systems. The Basel, Switzerland-based company made offers and even tried a hostile takeover attempt to pick up the molecular diagnostics

Hologic Shines With Gen-Probe MA In 2012, Hologic was growing significantly in its diagnostics offerings. But the Marlborough, MA-based company needed a bit more. The firm remedied this situation by making a move to acquire Gen-Probe for $3.

The diagnostics space is rapidly changing and growing. In May,a sessionon Center Stage at MDM East will address some of these changes in the in vitro diagnostics market along with fast growth markets and disruptive trends. We haveidentified

Bio-Rad Laboratories has received clearance from the US Food and Drug Administration for its first liquid biopsy assay and Droplet Digital PCR system for diagnostic use, the firm announced today. The test is designed for monitoring treatment